Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
Oncotarget|April 23, 2016
Gli-1/PI3K/AKT/NF-kB pathway mediates resistance to radiation and is a target for reversion of responses in refractory acute myeloid leukemia cellsXiaodong Li, Fang Chen, Qiuhua Zhu, et al.Oncotargets and Therapy|September 18, 2020
Integrative Genomic Analysis Reveals Cancer-Associated Gene Mutations in Chronic Myeloid Leukemia Patients with Resistance or Intolerance to Tyrosine Kinase InhibitorWaner Wu, Na Xu, Xuan Zhou, et al.Plos One|January 14, 2014
Identification of novel molecular markers for prognosis estimation of acute myeloid leukemia: over-expression of PDCD7, FIS1 and Ang2 may indicate poor prognosis in pretreatment patients with acute myeloid leukemiaYiming Tian, Zoufang Huang, Zhixiang Wang, et al.Bone Marrow Transplantation|October 25, 2019
Impact of FLT3-ITD allele ratio and ITD length on therapeutic outcome in cytogenetically normal AML patients without NPM1 mutationFang Chen, Junya Sun, Changxin Yin, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 23, 2016
Higher EZH2 expression is associated with extramedullary infiltration in acute myeloid leukemiaQiuhua Zhu, Lingxiu Zhang, Xiaodong Li, et al.Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|May 10, 2019
[Clinical characteristics of chronic myeloid leukemia with T315I mutation and the efficacy of ponatinib]Chen Chen, Na Xu, Xuejie Jiang, et al.Journal of Translational Medicine|March 21, 2021
Inhibition of EZH2 by chidamide exerts antileukemia activity and increases chemosensitivity through Smo/Gli-1 pathway in acute myeloid leukemiaXuejie Jiang, Ling Jiang, Jiaying Cheng, et al.Oncotarget|September 19, 2015
The hypomethylating agent decitabine prior to chemotherapy improves the therapy efficacy in refractory/relapsed acute myeloid leukemia patientsXuejie Jiang, Zhixiang Wang, Bingjie Ding, et al.Plos One|October 15, 2013
Herpesvirus-associated central nervous system diseases after allogeneic hematopoietic stem cell transplantationMeiqing Wu, Fen Huang, Xinmiao Jiang, et al.Cancer|March 7, 2018
Effect of sorafenib on the outcomes of patients with FLT3-ITD acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantationLi Xuan, Yu Wang, Fen Huang, et al.Pageof 4